October 24, 2018
InSysBio announces their participation at 19th International Conference on Systems Biology (ICSB 2018) to be held October 28th to November 1st, 2018 in Lyon, France. Two InSysBio posters will be presented:
“SBML viewer is a tool for transformation of systems biology models to human-readable format” by Viktoria Tkachenko and Evgeny Metelkin
in framework of Poster Session “Education for Systems Biologists. Novel methods and tools”
“An algorithm for practical identifiability analysis and confidence intervals evaluation based on constrained optimization” by Ivan Borisov and Evgeny Metelkin
in framework of Poster Session “Methodological developments for Systems Biology. Identifiability”
About InSysBio
InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.
| ← | May 2022 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
| ||||||
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
1.
24 May 2022 13:04
InSysBio to establish a new legal entity in Cyprus
InSysBio announces the creation of a new legal entity INSYSBIO CY Ltd. InSysBio continues the development of its QSP services and QSP tools infrastructure and contributing its experience to global research. Oleg Demin, CEO of InSysBio, comments on the significance and goals of this step.
|
25
|
26
|
27
|
28
|
29
|
|
30
|
31
| |||||
Thank you for your message! We will get back to you shortly.
